Qvar Redihaler Aerosol, Metered
Product Images NDC 59310-302

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Qvar Redihaler (NDC 59310-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Beclomethasone Dipropionate, the active ingredient in QVAR REDIHALER aerosol metered inhalation product by Teva Respiratory, LLC.*

FDA Label Image

Figure F (Image 10)

Packaging label for QVAR RediHaler 40 mcg metered dose inhaler by Teva Respiratory, LLC. The label includes the proprietary name, generic name beclomethasone dipropionate HFA, dosage form as breath-actuated inhalation aerosol, and strength of 40 mcg. It provides instructions to open the white cap, inhale deeply, and close the cap, with warnings not to shake or prime the inhaler. The package contains 120 metered inhalations with 10.6g net contents, labeled for prescription use only.*

FDA Label Image

Figure D (Image 11)

Packaging label for QVAR REDIHALER 40 mcg aerosol, metered dose inhaler containing beclomethasone dipropionate HFA. The label indicates it is a breath-actuated inhalation aerosol for oral inhalation only, with a net content of 120 metered inhalations. Manufactured by Teva Respiratory, LLC, the label includes usage instructions, warnings, and a barcode with the NDC 59310-302-40. The design also features flap instructions and a reminder to close the white cap before each use.*

FDA Label Image

Qvar® Redihaler™ (beclomethasone Dipropionate Hfa) 40 Mcg, 120 Metered Inhalations Carton, Part 1 Of 2 (Image 12)

QVAR REDIHALER 80 mcg metered dose inhaler label featuring beclomethasone dipropionate HFA as the active ingredient. The label includes usage instructions with illustrations for opening the white cap, inhaling deeply, and closing the cap. It notes 120 metered inhalations per container and cautions not to shake or prime the inhaler. Manufactured by Teva Respiratory, LLC, this is a breath-actuated inhalation aerosol for oral use.*

FDA Label Image

Qvar® Redihaler™ (beclomethasone Dipropionate Hfa) 40 Mcg, 120 Metered Inhalations Carton, Part 2 Of 2 (Image 13)

QVAR REDIHALER 80 mcg metered dose aerosol label for breath-actuated inhalation. The label includes the generic name Beclomethasone dipropionate HFA, specifies 120 metered inhalations, and notes oral inhalation use only. It features instructions to lift the side flap for inhaler usage guidance and highlights the breath-actuated (not press-and-breathe) mechanism with a closing cap requirement before inhalation. The labeler is Teva Respiratory, LLC.*

FDA Label Image

Image 2

Line graph showing FEV1 change from baseline (in liters) over 12 weeks, with measurements at Baseline, 2, 4, 8, and 12 weeks. It compares three groups: QVAR REDIHALER 80 mcg/day, QVAR REDIHALER 160 mcg/day, and Placebo, depicting lung function improvements over time for the two QVAR REDIHALER dosages versus placebo.*

FDA Label Image

Image 3

A line graph showing the change in FEV1 (L) from baseline over six weeks with four treatments: QVAR REDIHALER 320 mcg/day, QVAR REDIHALER 640 mcg/day, QVAR MDI 320 mcg/day, and placebo. The x-axis represents time in weeks (baseline, 2, 4, 6), and the y-axis represents FEV1 change in liters. Error bars indicate variability at each time point.*

FDA Label Image

Image 4

An instructional diagram of the QVAR REDIHALER aerosol inhaler showing labeled parts including the vent, mouthpiece, and white cap. The image provides a visual reference for the components of this respiratory inhalation device.*

FDA Label Image

Image 5

An illustration showing the dose counter feature on the QVAR REDIHALER inhaler. It displays two states: the full inhaler with 120 doses remaining and the empty inhaler with 0 doses. The diagram highlights the dose counter window on the bottom of the inhaler, indicating remaining doses for inhalation.*

FDA Label Image

Image 6

An instructional illustration showing hands opening the cap of a QVAR REDIHALER aerosol inhaler, indicated by an arrow and the word 'Click!' demonstrating the removal motion.*

FDA Label Image

Image 7

Illustration showing hands removing the cap from a QVAR REDIHALER metered dose inhaler by pulling the cap downward and away from the mouthpiece.*

FDA Label Image

Image 8

Illustration showing the correct use of the QVAR REDIHALER aerosol metered inhaler. It depicts a person holding the inhaler near their mouth while inhaling the medication through the respiratory route, with a cap being removed and an arrow indicating the inhalation direction.*

FDA Label Image

Image 9

An instructional black and white diagram showing a hand holding a QVAR REDIHALER aerosol inhaler with the mouthpiece cover being removed by lifting it away from the inhaler body. The illustration demonstrates how to prepare the inhaler for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.